Qiagen (QGEN) Up 8.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/06/25
Tracer Biotechnologies Announces Strategic Partnership with QIAGEN to Advance Blood-Based MRD Testing for Solid TumorsBusiness Wire • 06/05/25
QGEN Stock to Gain From Expanding Oncology Portfolio via New AlliancesZacks Investment Research • 06/03/25
QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnershipsBusiness Wire • 06/02/25
Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for LymphomaPRNewsWire • 06/02/25
QGEN Stock Might Gain Following New Partnership With ID SolutionsZacks Investment Research • 05/23/25
QIAGEN expands digital PCR oncology research portfolio through partnership with ID SolutionsBusiness Wire • 05/22/25
QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered softwareBusiness Wire • 05/12/25
QGEN Q1 Earnings and Revenues Top, Operating Margin Expands, Stock UpZacks Investment Research • 05/08/25
QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchaseBusiness Wire • 05/07/25
QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General MeetingBusiness Wire • 05/07/25
Stay Ahead of the Game With Qiagen (QGEN) Q1 Earnings: Wall Street's Insights on Key MetricsZacks Investment Research • 05/06/25
Activist Fivespan has a stake in Qiagen. Here are 3 levers to boost the company's growth and improve valueCNBC • 05/03/25
Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 04/30/25
QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality ControlBusiness Wire • 04/29/25
QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025Business Wire • 04/22/25